FDA Recalls Blood Pressure Medication due to Impurity Linked to Cancer Risk
The U.S. Food and Drug Administration (FDA) announced late last month that it was recalling the blood pressure medication Irbesartan. According to USA Today, the drug is manufactured by SciGen Pharmaceuticals, but packages will contain labels with brand names of Westminster Pharmaceuticals and Golden State Medical Supply, Inc. (GSMS).
Per the FDA, the affected medications are being recalled due to the presence of unsafe levels of N-nitrosodiethylamine (NDEA). The substance is labeled as a probable human carcinogen by the International Agency for Research on Cancer.
Affected lots of the medication include dosages containing 75 milligrams, 150 milligrams, and 300 milligrams and supplies include both 30-count and 90-count bottles. The FDA says that affected tables can be identified by their white coloring, oval shape, and the following markers:
- SG 160
- SG 161
- SG 162
If you were prescribed Irbesartan, talk to your doctor about your options. Never stop taking a medication without first consulting your physician.
At Ferrer, Poirot & Wansbrough, we’re always on the lookout for medications that can harm patients. Our drug injury lawyers know that medications can be recalled at any time after they’re linked to dangerous health problems. That’s why we’re here to help anyone who was harmed by a medication. Call us today for a free consultation.